About me:

Prof. Frayling has been working as a molecular geneticist for more than twenty years, the majority of that time with common human traits and diseases, particularly type 2 diabetes, obesity and related conditions. He obtained a personal chair as Professor of Human Genetics in 2007 and heads a team of 14 that has become internationally recognized as a world leader in the genetics of common traits and conditions. More information, including publications, is available on the team's website: http://www.t2diabetesgenes.org/

Outstanding contributions include the identification of the first genetic variants that influence adiposity (FTO, Science 2007) height (HMGA2, Nature Genetics 2007, Nature 2010) and birth weight (ADCY5, CDKAL1, Nature Genetics 2010) in the general population.

His training began as a Clinical Grade A trainee molecular geneticist in the Churchill Hospital, Oxford, where he learnt the basics of human genetics including linkage analyses in Duchenne Muscular Dystrophy and Bayesian statistics in Cystic fibrosis risk calculations. He began his research career in 1996 in Exeter in the field of monogenic forms of diabetes. His work, as a PhD student with Prof Andrew Hattersley, played a key role in the characterization of the genes for maturity onset diabetes of the young. Key work prior to the genome wide association studies includes some of the first use of meta-analyses and multiple replication studies to determine the role of common variants in disease. These include the assessment of common variants in the KCNJ11 (E23K variant, Diabetes 2003) gene in type 2 diabetes risk and the identification of the first robust associations between common variants and birth weight (TCF7L2 and Glucokinase, AJHG 2006 & 2007).

Broad research specialisms

He and his colleagues focus on using genome wide approaches to identify genetic variation associated with common human disease and quantitative phenotypes and translating that knowledge into an improved understanding of disease biology.

They are members of several large collaborations that are continuing to identify more variants in the human genome that influence important human traits. They are translating these genetic associations into an improved understanding of the biological basis of disease and normal physiology. Examples include Mendelian Randomization studies that provide evidence for a role of sex-hormones in type 2 diabetes, links between fetal growth and type 2 diabetes, and, genetic variants that increase adiposity but lower risk of metabolic diseases.

Interests:

Prof. Frayling gives an overview of research carried out by his interdisciplinary team at RILD (the Research, Innovation, Learning and Development Centre) in the video below, filmed at the Living Systems Institute Symposium 2016.

[embed:32]

Qualifications:

• PhD, 1998